Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase
- 15 April 2008
- journal article
- Published by Elsevier BV in Immunology Letters
- Vol. 117 (1), 81-90
- https://doi.org/10.1016/j.imlet.2007.12.013
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The Biology of NKT CellsAnnual Review of Immunology, 2007
- Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of miceProceedings of the National Academy of Sciences of the United States of America, 2006
- Functionally distinct NKT cell subsets and subtypesThe Journal of Experimental Medicine, 2005
- Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan MetaboliteScience, 2005
- Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivoTransplant International, 2005
- Tolerance, DCs and tryptophan: much ado about IDOTrends in Immunology, 2003
- Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-DioxygenaseThe Journal of Experimental Medicine, 2002
- Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic CellsThe Journal of Experimental Medicine, 2002
- CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lungNature Medicine, 2002
- Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesisEuropean Journal of Immunology, 1999